Search results
Largest U.S. Pension Sold Verizon, Disney, and Peloton Stock. It Bought Moderna.
Barrons.com· 11 hours agoBoth shares beat the market in the first quarter, with Verizon... in the past week reported a strong...
On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23
FierceBiotech· 6 days agoFive months ago, Merck revealed data that indicate its next-generation pneumococcal vaccine offers more protection for older adults than Pfizer’s market dominator Prevnar ...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 3 days agoModerna Stock: Technical...The RS Rating is a 1-99 measure of a stock's 12-month performance. This...
3 No-Brainer Stocks to Buy in May
Motley Fool via Yahoo Finance· 7 hours agoThe 10 stocks that made the cut could produce monster returns in the coming years. Consider when Nvidia made this list on April 15, 2005... if you...
FDA Says Vaccination Is the Best Protection Against Measles
Sierra Sun Times· 6 days agoMeasles is one of the most contagious respiratory diseases in the world that has the potential to be life-threatening. Vaccines approved by the U.S. Food and Drug Administration ...
Realising the potential of correlates of protection for vaccine development, licensure and use:...
Nature· 6 days agoVaccines have had a significant impact on global morbidity and mortality over the last century, with estimates indicating that millions of lives are saved each year as a result ...
Who will RFK Jr. hurt more in 2024: Trump or Biden?
Yahoo News 360· 3 days ago12%); that vaccines cause autism (25% vs. 5%); and that chemicals in the water supply could turn children transgender (8% vs. 4%). For now, the Yahoo...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 4 days agoSI&A spending is expected in the range of $13...billion to $14.8 billion. The adjusted tax rate is...
Biotech Stocks Facing FDA Decision In May 2024
RTT News· 5 days agoAs April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing to a total of 55 approvals ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 4 days agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...
